PedAM
Pediatric Disease Annotations & Medicines
| Disease | colorectal cancer |
| Phenotype | C0948303|peritoneal carcinoma |
| Sentences | 26 |
| PubMedID- 20182517 | This combination strategy may provide a new avenue to treating peritoneal carcinomatosis and other types of metastases of colorectal cancer. |
| PubMedID- 23247560 | Until recently peritoneal carcinomatosis (pc) arising from colorectal cancer (crc) was considered to be a terminal disease manifestation. |
| PubMedID- 23022755 | peritoneal carcinomatosis (pc) arising from colorectal cancer (crc) is generally considered a terminal condition with few treatment options. |
| PubMedID- 25156007 | Oxaliplatin and molecular-targeted drug therapies improved the overall survival in colorectal cancer patients with synchronous peritoneal carcinomatosis undergoing incomplete cytoreductive surgery. |
| PubMedID- 22084764 | It is important to note that significant difference in the rate of recurrence has been documented for colorectal cancer with peritoneal carcinomatosis [25]. |
| PubMedID- 22572106 | Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy. |
| PubMedID- 26264074 | Introduction: treatment for advanced stage colorectal cancer with synchronous peritoneal carcinomatosis (pc) and hepatic metastasis (hm) has progressed significantly over the past 10 years. |
| PubMedID- 24801982 | Brain-derived neurotrophic factor (bdnf)-induced tropomyosin-related kinase b (trk b) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer. |
| PubMedID- 24720439 | Background: peritoneal carcinomatosis (pc) arising from colorectal cancer is associated with poor prognosis and few treatment options are currently available. |
| PubMedID- 21558398 | Purpose: here, we aimed to investigate the role of connective tissue growth factor (ctgf) in peritoneal carcinomatosis (pc) associated with colorectal cancer (crc) and to characterize the underlying mechanism of ctgf mediating adhesion. |
| PubMedID- 25680955 | Background: population-based data on the percentage of colorectal cancer (crc) patients with synchronous peritoneal carcinomatosis (pc) being treated with cytoreductive surgery (crs) and hyperthermic intraperitoneal chemotherapy (hipec) are currently lacking. |
| PubMedID- 24018983 | Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from colorectal cancer. |
| PubMedID- 25157365 | The objective of this study is to describe the epithelial-mesenchymal transition in terms of gene expression profile and somatic alterations in samples of colorectal cancer with or without peritoneal carcinomatosis. |
| PubMedID- 24393986 | [efficacy of oxaliplatin-based chemotherapy in stage iv colorectal cancer patients with peritoneal carcinomatosis]. |
| PubMedID- 23391248 | A prospective multicenter phase ii study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the combatac trial. |
| PubMedID- 22247707 | A phase ii study of modified folfox4 for colorectal cancer patients with peritoneal carcinomatosis. |
| PubMedID- 21679595 | Between 1998 and 2007, 126 patients who underwent surgical treatment for primary colorectal cancer with peritoneal carcinomatosis were retrospectively assessed concerning prognostic factors. |
| PubMedID- 23810334 | Aim: to compare the clinical outcome of a one-stage, primary tumour resection and hyperthermic intraperitoneal chemotherapy (hipec) procedure, versus a two-stage procedure of tumour resection and secondary hipec in colorectal cancer (crc) patients with synchronous peritoneal carcinomatosis. |
| PubMedID- 22614990 | Prognosis of colorectal cancer with peritoneal carcinomatosis: is a new staging necessary. |
| PubMedID- 21176934 | Clinical impact of a macroscopically complete resection of colorectal cancer with peritoneal carcinomatosis. |
| PubMedID- 24854493 | Background: extensive clinical experience suggests that hyperthermic intraperitoneal chemotherapy (hipec) may play an important role in the management of colorectal cancer patients with peritoneal carcinomatosis (crcpc). |
| PubMedID- 22397952 | peritoneal carcinomatosis (pc) arising from colorectal cancer (crc) is generally considered a terminal condition with no treatment options. |
| PubMedID- 23359115 | colorectal cancer (crc) patients with peritoneal carcinomatosis (pc) have a poor prognosis. |
| PubMedID- 25895028 | This is especially clinically important for colorectal cancer patients with peritoneal carcinomatosis as these lesions are generally small, difficult to distinguish from adjacent normal tissue and numerous. |
| PubMedID- 20186492 | Current status of colorectal cancer with peritoneal carcinomatosis. |
| PubMedID- 26231227 | 1a-c pet-ct pathologic uptake in the pelvis, revealing peritoneal carcinomatosis of colorectal cancerfig. |
Page: 1